Search results
Results from the WOW.Com Content Network
Haleon was established on 18 July 2022 as a corporate spin-off from GSK. [6] Sir Dave Lewis is chairman, with Brian McNamara as CEO. [7] Haleon is listed on the London Stock Exchange and is a component of the FTSE 100, with a secondary listing on the New York Stock Exchange. Annual sales amounted to around £10 billion across 120 markets in ...
Haleon was formed in 2019 by merging GSK and Pfizer's consumer healthcare businesses. The disposal will be conducted via placing of shares in Haleon to institutional investors.
GSK earlier this year sold 240 million shares in Haleon to raise about 804 million pounds ($1 billion), and lowered its stake from 12.9% it initially retained in the business.
GSK sold around 385 million shares at 324 pence apiece, amounting to a 4.2% stake in Haleon. The company was formed in a merger of GSK and Pfizer's consumer healthcare businesses in 2019. The sale ...
GSK plc (an acronym from its former name GlaxoSmithKline plc) is a British multinational pharmaceutical and biotechnology company with headquarters in London. [3] [4] It was established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham, [n 1] which was itself a merger of a number of pharmaceutical companies around the Smith, Kline & French firm.
Shares in Haleon, which was created by the merger of GSK and Pfizer's consumer healthcare businesses in 2019 and spun off from the British drugmaker in 2022, fell 1.2% to 388 pence in morning ...
Centrum is an American brand of multivitamins produced by Haleon. It was designed by Dr. Ellenbogen's team, working at Lederle Laboratories, and was introduced in 1978. It has been owned by Wyeth, Pfizer, GSK. [1], and now Haleon. Centrum multivitamins in Australasian packaging
Haleon has been focused on cutting debt by selling brands such as Lamisil and Chapstick and keeping a lid on costs. After being spun-off from drugmaker GSK in 2022, it cut debt by over 2 billion ...